SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a ...
Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior ...
The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approach ...
After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. In turn, Agilent ...
It has been about a month since the last earnings report for Agilent Technologies (A). Shares have added about 9.6% in that ...
Agilent Technologies (A) has an average rating of overweight and mean price target of $177.33, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research ...
Follow Agilent Technologies, as investors assess operating repair and valuation discipline, the current catalyst, execution risks and the company evidence that may shape its next market move.
Agilent Technologies (NYSE:A) will release its quarterly earnings report on Wednesday, 2025-05-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Agilent ...
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell ...
Agilent Technologies, a $35 billion leader in global life sciences, is trading 30% below its all-time high and 20% down year-to-date, presenting a potential growth/value opportunity. Despite ...
SANTA CLARA, Calif. -- (BUSINESS WIRE)--Sep. 29, 2026-- Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis ...